Abbott's TriClip ™ Becomes First Device of its Kind to Receive CE Mark for Minimally Invasive Tricuspid Valve Repair

- CE Mark for TriClip represents an important treatment option for people with severe tricuspid regurgitation, a difficult-to-manage heart condition
Source: Abbott.com - Category: Pharmaceuticals Source Type: news

Related Links:

Publication date: June 2020Source: IJC Heart &Vasculature, Volume 28Author(s): Waqas Ullah, Yasar Sattar, Maryam Mukhtar, Hafez M. Abdullah, Vincent M. Figueredo, Donald C. Haas, David L. Fischman, M. Chadi Alraies
Source: IJC Heart and Vasculature - Category: Cardiology Source Type: research
European Journal of Heart Failure, EarlyView.
Source: European Journal of Heart Failure - Category: Cardiology Authors: Tags: Editorial Comment Source Type: research
European Journal of Heart Failure, EarlyView.
Source: European Journal of Heart Failure - Category: Cardiology Authors: Tags: Editorial Comment Source Type: research
AbstractAimsThe aim of this study was to compare the outcomes of surgical mitral valve repair or replacement (sMVR) and percutaneous edge ‐to‐edge repair using MitraClip (pMVR) in patients with severe left ventricular dysfunction affected by functional mitral regurgitation (FMR).Methods and resultsWe retrospectively identified 132 patients with left ventricular ejection fraction (LVEF)  ≦ 30% submitted to sMVR (n = 47) or pMVR (n = 85) for FMR at our centre from January 2013 to December 2017. To adjust for baseline imbalances, we used a propensity score matching by age, logistic EuroSCOR...
Source: ESC Heart Failure - Category: Cardiology Authors: Tags: Original Research Article Source Type: research
This study's purpose is to determine the effect of a previously unassessed measure of quality of care —a hospital's preventable hospitalization rate—on 30-day mortality at both the hospital and individual levels after three major cardiovascular surgery procedures. This is a population-based study using Taiwan's National Health Insurance database. We retrieved data from 2001-2014 for patients who had undergone abdominal aortic aneurysm (AAA) repair, coronary artery bypass graft (CABG), or aortic valve replacement (AVR).
Source: Seminars in Thoracic and Cardiovascular Surgery - Category: Cardiovascular & Thoracic Surgery Authors: Tags: ADULT – Original Submission Source Type: research
Abstract An anomalous right coronary artery arising from the left coronary sinus is a rare anatomic variant. Here, we report a patient who presented with an acute type A dissection and underwent successful aortic root reconstruction with resuspension of the aortic valve and neomedia creation in the presence of an anomalous right coronary artery with a good clinical outcome. PMID: 32445633 [PubMed - as supplied by publisher]
Source: The Annals of Thoracic Surgery - Category: Cardiovascular & Thoracic Surgery Authors: Tags: Ann Thorac Surg Source Type: research
We present an adult male with right sided infective endocarditis where pulmonary valve cusps were almost completely damaged. Pulmonary valve was successfully reconstructed using glutaraldehyde treated autologous pericardium by Ozaki technique. Ozaki repair was originally described for aortic valve repair in various aortic valve diseases. PMID: 32445631 [PubMed - as supplied by publisher]
Source: The Annals of Thoracic Surgery - Category: Cardiovascular & Thoracic Surgery Authors: Tags: Ann Thorac Surg Source Type: research
AbstractAimsThe purpose of this study is to identify echocardiography predictors of clinical response and reverse left ventricular (LV) remodelling in patients with functional mitral regurgitation (FMR) treated with MitraClip.Method and resultsWe retrospectively analysed 86 high surgical risk patients with severe FMR; of those, 58 were implanted a MitraClip, and 28 received medical treatment and served as controls. At baseline and at 1 ‐year follow‐up, we performed clinical and echocardiography evaluation to assess global longitudinal strain (GLS) and myocardial work [global work index (GWI), global constructive work (...
Source: ESC Heart Failure - Category: Cardiology Authors: Tags: Original Research Article Source Type: research
Condition:   Severe Degenerative Mitral Regurgitation Due to Mid-segment Posterior Leaflet Prolapse Intervention:   Device: HARPOON Beating Heart Mitral Valve Repair System (MVRS) Sponsors:   Edwards Lifesciences;   MedPass International Not yet recruiting
Source: ClinicalTrials.gov - Category: Research Source Type: clinical trials
More News: Cardiology | Gastroschisis Repair | Heart | Heart Valve Surgery | Pharmaceuticals